Global EPA / DHA/ALA (Omega 3) Market Growth 2020-2025


COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of EPA / DHA/ALA (Omega 3) will have significant change from previous year. By the most conservative estimates of global EPA / DHA/ALA (Omega 3) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the EPA / DHA/ALA (Omega 3) market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of EPA / DHA/ALA (Omega 3) market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the EPA / DHA/ALA (Omega 3), covering the supply chain analysis, impact assessment to the EPA / DHA/ALA (Omega 3) market size growth rate in several scenarios, and the measures to be undertaken by EPA / DHA/ALA (Omega 3) companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
    Fish Oil
    Algae Oil

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
    Dietary Supplements
    Functional Foods & Beverages
    Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
    EPAX
    Golden Omega
    Omega Protein
    Croda
    TASA
    Polaris
    KD Pharma
    Auqi
    GC Rieber

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
    To study and analyze the global EPA / DHA/ALA (Omega 3) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
    To understand the structure of EPA / DHA/ALA (Omega 3) market by identifying its various subsegments.
    Focuses on the key global EPA / DHA/ALA (Omega 3) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the EPA / DHA/ALA (Omega 3) with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of EPA / DHA/ALA (Omega 3) submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
    1.1 Market Introduction
    1.2 Research Objectives
    1.3 Years Considered
    1.4 Market Research Methodology
    1.5 Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 What is the Impact of Covid-19 Outbreak On the EPA / DHA/ALA (Omega 3)?
        1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
        1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
        1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global EPA / DHA/ALA (Omega 3) Market Size in 2020, by Scenario
        1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global EPA / DHA/ALA (Omega 3) Consumption 2015-2025
        2.1.2 EPA / DHA/ALA (Omega 3) Consumption CAGR by Region
    2.2 EPA / DHA/ALA (Omega 3) Segment by Type
        2.2.1 Fish Oil
        2.2.2 Algae Oil
    2.3 EPA / DHA/ALA (Omega 3) Consumption by Type
        2.3.1 Global EPA / DHA/ALA (Omega 3) Consumption Market Share by Type (2015-2020)
        2.3.2 Global EPA / DHA/ALA (Omega 3) Revenue and Market Share by Type (2015-2020)
        2.3.3 Global EPA / DHA/ALA (Omega 3) Sale Price by Type (2015-2020)
    2.4 EPA / DHA/ALA (Omega 3) Segment by Application
        2.4.1 Dietary Supplements
        2.4.2 Functional Foods & Beverages
        2.4.3 Others
    2.5 EPA / DHA/ALA (Omega 3) Consumption by Application
        2.5.1 Global EPA / DHA/ALA (Omega 3) Consumption Market Share by Type (2015-2020)
        2.5.2 Global EPA / DHA/ALA (Omega 3) Value and Market Share by Type (2015-2020)
        2.5.3 Global EPA / DHA/ALA (Omega 3) Sale Price by Type (2015-2020)

3 Global EPA / DHA/ALA (Omega 3) by Company
    3.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Company
        3.1.1 Global EPA / DHA/ALA (Omega 3) Sales by Company (2018-2020)
        3.1.2 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Company (2018-2020)
    3.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Company
        3.2.1 Global EPA / DHA/ALA (Omega 3) Revenue by Company (2018-2020)
        3.2.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Company (2018-2020)
    3.3 Global EPA / DHA/ALA (Omega 3) Sale Price by Company
    3.4 Global EPA / DHA/ALA (Omega 3) Manufacturing Base Distribution, Sales Area, Type by Company
        3.4.1 Global EPA / DHA/ALA (Omega 3) Manufacturing Base Distribution and Sales Area by Company
        3.4.2 Players EPA / DHA/ALA (Omega 3) Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 EPA / DHA/ALA (Omega 3) by Regions
    4.1 EPA / DHA/ALA (Omega 3) by Regions
    4.2 Americas EPA / DHA/ALA (Omega 3) Consumption Growth
    4.3 APAC EPA / DHA/ALA (Omega 3) Consumption Growth
    4.4 Europe EPA / DHA/ALA (Omega 3) Consumption Growth
    4.5 Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption Growth

5 Americas
    5.1 Americas EPA / DHA/ALA (Omega 3) Consumption by Countries
        5.1.1 Americas EPA / DHA/ALA (Omega 3) Consumption by Countries (2015-2020)
        5.1.2 Americas EPA / DHA/ALA (Omega 3) Value by Countries (2015-2020)
    5.2 Americas EPA / DHA/ALA (Omega 3) Consumption by Type
    5.3 Americas EPA / DHA/ALA (Omega 3) Consumption by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
    5.8 Key Economic Indicators of Few Americas Countries

6 APAC
    6.1 APAC EPA / DHA/ALA (Omega 3) Consumption by Regions
        6.1.1 APAC EPA / DHA/ALA (Omega 3) Consumption by Regions (2015-2020)
        6.1.2 APAC EPA / DHA/ALA (Omega 3) Value by Regions (2015-2020)
    6.2 APAC EPA / DHA/ALA (Omega 3) Consumption by Type
    6.3 APAC EPA / DHA/ALA (Omega 3) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
    7.1 Europe EPA / DHA/ALA (Omega 3) by Countries
        7.1.1 Europe EPA / DHA/ALA (Omega 3) Consumption by Countries (2015-2020)
        7.1.2 Europe EPA / DHA/ALA (Omega 3) Value by Countries (2015-2020)
    7.2 Europe EPA / DHA/ALA (Omega 3) Consumption by Type
    7.3 Europe EPA / DHA/ALA (Omega 3) Consumption by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
    7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
    8.1 Middle East & Africa EPA / DHA/ALA (Omega 3) by Countries
        8.1.1 Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption by Countries (2015-2020)
        8.1.2 Middle East & Africa EPA / DHA/ALA (Omega 3) Value by Countries (2015-2020)
    8.2 Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption by Type
    8.3 Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Marketing, Distributors and Customer
    10.1 Sales Channel
        10.1.1 Direct Channels
        10.1.2 Indirect Channels
    10.2 EPA / DHA/ALA (Omega 3) Distributors
    10.3 EPA / DHA/ALA (Omega 3) Customer

11 Global EPA / DHA/ALA (Omega 3) Market Forecast
    11.1 Global EPA / DHA/ALA (Omega 3) Consumption Forecast (2021-2025)
    11.2 Global EPA / DHA/ALA (Omega 3) Forecast by Regions
        11.2.1 Global EPA / DHA/ALA (Omega 3) Forecast by Regions (2021-2025)
        11.2.2 Global EPA / DHA/ALA (Omega 3) Value Forecast by Regions (2021-2025)
        11.2.3 Americas Consumption Forecast
        11.2.4 APAC Consumption Forecast
        11.2.5 Europe Consumption Forecast
        11.2.6 Middle East & Africa Consumption Forecast
    11.3 Americas Forecast by Countries
        11.3.1 United States Market Forecast
        11.3.2 Canada Market Forecast
        11.3.3 Mexico Market Forecast
        11.3.4 Brazil Market Forecast
   11.4 APAC Forecast by Countries
        11.4.1 China Market Forecast
        11.4.2 Japan Market Forecast
        11.4.3 Korea Market Forecast
        11.4.4 Southeast Asia Market Forecast
        11.4.5 India Market Forecast
        11.4.6 Australia Market Forecast
    11.5 Europe Forecast by Countries
        11.5.1 Germany Market Forecast
        11.5.2 France Market Forecast
        11.5.3 UK Market Forecast
        11.5.4 Italy Market Forecast
        11.5.5 Russia Market Forecast
    11.6 Middle East & Africa Forecast by Countries
        11.6.1 Egypt Market Forecast
        11.6.2 South Africa Market Forecast
        11.6.3 Israel Market Forecast
        11.6.4 Turkey Market Forecast
        11.6.5 GCC Countries Market Forecast
    11.7 Global EPA / DHA/ALA (Omega 3) Forecast by Type
    11.8 Global EPA / DHA/ALA (Omega 3) Forecast by Application

12 Key Players Analysis
    12.1 EPAX
        12.1.1 Company Information
        12.1.2 EPA / DHA/ALA (Omega 3) Product Offered
        12.1.3 EPAX EPA / DHA/ALA (Omega 3) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.1.4 Main Business Overview
        12.1.5 EPAX Latest Developments
    12.2 Golden Omega
        12.2.1 Company Information
        12.2.2 EPA / DHA/ALA (Omega 3) Product Offered
        12.2.3 Golden Omega EPA / DHA/ALA (Omega 3) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.2.4 Main Business Overview
        12.2.5 Golden Omega Latest Developments
    12.3 Omega Protein
        12.3.1 Company Information
        12.3.2 EPA / DHA/ALA (Omega 3) Product Offered
        12.3.3 Omega Protein EPA / DHA/ALA (Omega 3) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.3.4 Main Business Overview
        12.3.5 Omega Protein Latest Developments
    12.4 Croda
        12.4.1 Company Information
        12.4.2 EPA / DHA/ALA (Omega 3) Product Offered
        12.4.3 Croda EPA / DHA/ALA (Omega 3) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.4.4 Main Business Overview
        12.4.5 Croda Latest Developments
    12.5 TASA
        12.5.1 Company Information
        12.5.2 EPA / DHA/ALA (Omega 3) Product Offered
        12.5.3 TASA EPA / DHA/ALA (Omega 3) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.5.4 Main Business Overview
        12.5.5 TASA Latest Developments
    12.6 Polaris
        12.6.1 Company Information
        12.6.2 EPA / DHA/ALA (Omega 3) Product Offered
        12.6.3 Polaris EPA / DHA/ALA (Omega 3) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.6.4 Main Business Overview
        12.6.5 Polaris Latest Developments
    12.7 KD Pharma
        12.7.1 Company Information
        12.7.2 EPA / DHA/ALA (Omega 3) Product Offered
        12.7.3 KD Pharma EPA / DHA/ALA (Omega 3) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.7.4 Main Business Overview
        12.7.5 KD Pharma Latest Developments
    12.8 Auqi
        12.8.1 Company Information
        12.8.2 EPA / DHA/ALA (Omega 3) Product Offered
        12.8.3 Auqi EPA / DHA/ALA (Omega 3) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.8.4 Main Business Overview
        12.8.5 Auqi Latest Developments
    12.9 GC Rieber
        12.9.1 Company Information
        12.9.2 EPA / DHA/ALA (Omega 3) Product Offered
        12.9.3 GC Rieber EPA / DHA/ALA (Omega 3) Sales, Revenue, Price and Gross Margin (2018-2020)
        12.9.4 Main Business Overview
        12.9.5 GC Rieber Latest Developments

13 Research Findings and Conclusion

List of Tables Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global EPA / DHA/ALA (Omega 3) Market Size in 2020, by Scenario Table 2. COVID-19: Measures to be Undertaken by EPA / DHA/ALA (Omega 3) Companies Table 3. Research Methodology Table 4. Data Source Table 5. EPA / DHA/ALA (Omega 3) Consumption CAGR by Region 2015-2025 ($ Millions) Table 6. Major Players of Fish Oil Table 7. Major Players of Algae Oil Table 8. Global Consumption Sales by Type (2015-2020) Table 9. Global EPA / DHA/ALA (Omega 3) Consumption Market Share by Type (2015-2020) Table 10. Global EPA / DHA/ALA (Omega 3) Revenue by Type (2015-2020) ($ million) Table 11. Global EPA / DHA/ALA (Omega 3) Value Market Share by Type (2015-2020) ($ Millions) Table 12. Global EPA / DHA/ALA (Omega 3) Sale Price by Type (2015-2020) Table 13. Global Consumption Sales by Application (2015-2020) Table 14. Global EPA / DHA/ALA (Omega 3) Consumption Market Share by Application (2015-2020) Table 15. Global EPA / DHA/ALA (Omega 3) Value by Application (2015-2020) Table 16. Global EPA / DHA/ALA (Omega 3) Value Market Share by Application (2015-2020) Table 17. Global EPA / DHA/ALA (Omega 3) Sale Price by Application (2015-2020) Table 18. Global EPA / DHA/ALA (Omega 3) Sales by Company (2017-2019) (K Units) Table 19. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Company (2017-2019) Table 20. Global EPA / DHA/ALA (Omega 3) Revenue by Company (2017-2019) ($ Millions) Table 21. Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Company (2017-2019) Table 22. Global EPA / DHA/ALA (Omega 3) Sale Price by Company (2017-2019) Table 23. Global EPA / DHA/ALA (Omega 3) Manufacturing Base Distribution and Sales Area by Manufacturers Table 24. Players EPA / DHA/ALA (Omega 3) Products Offered Table 25. EPA / DHA/ALA (Omega 3) Concentration Ratio (CR3, CR5 and CR10) (2017-2019) Table 26. Global EPA / DHA/ALA (Omega 3) Consumption by Regions 2015-2020 (K Units) Table 27. Global EPA / DHA/ALA (Omega 3) Consumption Market Share by Regions 2015-2020 Table 28. Global EPA / DHA/ALA (Omega 3) Value by Regions 2015-2020 ($ Millions) Table 29. Global EPA / DHA/ALA (Omega 3) Value Market Share by Regions 2015-2020 Table 30. Americas EPA / DHA/ALA (Omega 3) Consumption by Countries (2015-2020) (K Units) Table 31. Americas EPA / DHA/ALA (Omega 3) Consumption Market Share by Countries (2015-2020) Table 32. Americas EPA / DHA/ALA (Omega 3) Value by Countries (2015-2020) ($ Millions) Table 33. Americas EPA / DHA/ALA (Omega 3) Value Market Share by Countries (2015-2020) Table 34. Americas EPA / DHA/ALA (Omega 3) Consumption by Type (2015-2020) (K Units) Table 35. Americas EPA / DHA/ALA (Omega 3) Consumption Market Share by Type (2015-2020) Table 36. Americas EPA / DHA/ALA (Omega 3) Consumption by Application (2015-2020) (K Units) Table 37. Americas EPA / DHA/ALA (Omega 3) Consumption Market Share by Application (2015-2020) Table 38. APAC EPA / DHA/ALA (Omega 3) Consumption by Countries (2015-2020) (K Units) Table 39. APAC EPA / DHA/ALA (Omega 3) Consumption Market Share by Countries (2015-2020) Table 40. APAC EPA / DHA/ALA (Omega 3) Value by Regions (2015-2020) ($ Millions) Table 41. APAC EPA / DHA/ALA (Omega 3) Value Market Share by Regions (2015-2020) Table 42. APAC EPA / DHA/ALA (Omega 3) Consumption by Type (2015-2020) (K Units) Table 43. APAC EPA / DHA/ALA (Omega 3) Consumption Market Share by Type (2015-2020) Table 44. APAC EPA / DHA/ALA (Omega 3) Consumption by Application (2015-2020) (K Units) Table 45. APAC EPA / DHA/ALA (Omega 3) Consumption Market Share by Application (2015-2020) Table 46. Europe EPA / DHA/ALA (Omega 3) Consumption by Countries (2015-2020) (K Units) Table 47. Europe EPA / DHA/ALA (Omega 3) Consumption Market Share by Countries (2015-2020) Table 48. Europe EPA / DHA/ALA (Omega 3) Value by Countries (2015-2020) ($ Millions) Table 49. Europe EPA / DHA/ALA (Omega 3) Value Market Share by Countries (2015-2020) Table 50. Europe EPA / DHA/ALA (Omega 3) Consumption by Type (2015-2020) (K Units) Table 51. Europe EPA / DHA/ALA (Omega 3) Consumption Market Share by Type (2015-2020) Table 52. Europe EPA / DHA/ALA (Omega 3) Consumption by Application (2015-2020) (K Units) Table 53. Europe EPA / DHA/ALA (Omega 3) Consumption Market Share by Application (2015-2020) Table 54. Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption by Countries (2015-2020) (K Units) Table 55. Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption Market Share by Countries (2015-2020) Table 56. Middle East & Africa EPA / DHA/ALA (Omega 3) Value by Countries (2015-2020) ($ Millions) Table 57. Middle East & Africa EPA / DHA/ALA (Omega 3) Value Market Share by Countries (2015-2020) Table 58. Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption by Type (2015-2020) (K Units) Table 59. Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption Market Share by Type (2015-2020) Table 60. Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption by Application (2015-2020) (K Units) Table 61. Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption Market Share by Application (2015-2020) Table 62. EPA / DHA/ALA (Omega 3) Distributors List Table 63. EPA / DHA/ALA (Omega 3) Customer List Table 64. Global EPA / DHA/ALA (Omega 3) Consumption Forecast by Countries (2021-2025) (K Units) Table 65. Global EPA / DHA/ALA (Omega 3) Consumption Market Forecast by Regions Table 66. Global EPA / DHA/ALA (Omega 3) Value Forecast by Countries (2021-2025) ($ Millions) Table 67. Global EPA / DHA/ALA (Omega 3) Value Market Share Forecast by Regions Table 68. Global EPA / DHA/ALA (Omega 3) Consumption Forecast by Type (2021-2025) (K Units) Table 69. Global EPA / DHA/ALA (Omega 3) Consumption Market Share Forecast by Type (2021-2025) Table 70. Global EPA / DHA/ALA (Omega 3) Value Forecast by Type (2021-2025) ($ Millions) Table 71. Global EPA / DHA/ALA (Omega 3) Value Market Share Forecast by Type (2021-2025) Table 72. Global EPA / DHA/ALA (Omega 3) Consumption Forecast by Application (2021-2025) (K Units) Table 73. Global EPA / DHA/ALA (Omega 3) Consumption Market Share Forecast by Application (2021-2025) Table 74. Global EPA / DHA/ALA (Omega 3) Value Forecast by Application (2021-2025) ($ Millions) Table 75. Global EPA / DHA/ALA (Omega 3) Value Market Share Forecast by Application (2021-2025) Table 76. EPAX Product Offered Table 77. EPAX EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E) Table 78. EPAX Main Business Table 79. EPAX Latest Developments Table 80. EPAX Basic Information, Company Total Revenue (in $ million), EPA / DHA/ALA (Omega 3) Manufacturing Base, Sales Area and Its Competitors Table 81. Golden Omega Product Offered Table 82. Golden Omega EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E) Table 83. Golden Omega Main Business Table 84. Golden Omega Latest Developments Table 85. Golden Omega Basic Information, Company Total Revenue (in $ million), EPA / DHA/ALA (Omega 3) Manufacturing Base, Sales Area and Its Competitors Table 86. Omega Protein Product Offered Table 87. Omega Protein EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E) Table 88. Omega Protein Main Business Table 89. Omega Protein Latest Developments Table 90. Omega Protein Basic Information, Company Total Revenue (in $ million), EPA / DHA/ALA (Omega 3) Manufacturing Base, Sales Area and Its Competitors Table 91. Croda Product Offered Table 92. Croda EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E) Table 93. Croda Main Business Table 94. Croda Latest Developments Table 95. Croda Basic Information, Company Total Revenue (in $ million), EPA / DHA/ALA (Omega 3) Manufacturing Base, Sales Area and Its Competitors Table 96. TASA Product Offered Table 97. TASA EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E) Table 98. TASA Main Business Table 99. TASA Latest Developments Table 100. TASA Basic Information, Company Total Revenue (in $ million), EPA / DHA/ALA (Omega 3) Manufacturing Base, Sales Area and Its Competitors Table 101. Polaris Product Offered Table 102. Polaris EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E) Table 103. Polaris Main Business Table 104. Polaris Latest Developments Table 105. Polaris Basic Information, Company Total Revenue (in $ million), EPA / DHA/ALA (Omega 3) Manufacturing Base, Sales Area and Its Competitors Table 106. KD Pharma Product Offered Table 107. KD Pharma Basic Information, Company Total Revenue (in $ million), EPA / DHA/ALA (Omega 3) Manufacturing Base, Sales Area and Its Competitors Table 108. KD Pharma Main Business Table 109. KD Pharma Latest Developments Table 110. KD Pharma EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E) Table 111. Auqi Product Offered Table 112. Auqi EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E) Table 113. Auqi Main Business Table 114. Auqi Latest Developments Table 115. Auqi Basic Information, Company Total Revenue (in $ million), EPA / DHA/ALA (Omega 3) Manufacturing Base, Sales Area and Its Competitors Table 116. GC Rieber Product Offered Table 117. GC Rieber EPA / DHA/ALA (Omega 3) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E) Table 118. GC Rieber Main Business Table 119. GC Rieber Latest Developments Table 120. GC Rieber Basic Information, Company Total Revenue (in $ million), EPA / DHA/ALA (Omega 3) Manufacturing Base, Sales Area and Its Competitors List of Figures Figure 1. Picture of EPA / DHA/ALA (Omega 3) Figure 2. EPA / DHA/ALA (Omega 3) Report Years Considered Figure 3. Market Research Methodology Figure 4. Global EPA / DHA/ALA (Omega 3) Consumption Growth Rate 2015-2025 (K Units) Figure 5. Global EPA / DHA/ALA (Omega 3) Value Growth Rate 2015-2025 ($ Millions) Figure 6. Product Picture of Fish Oil Figure 7. Product Picture of Algae Oil Figure 8. Global EPA / DHA/ALA (Omega 3) Consumption Market Share by Type (2015-2020) Figure 9. Global EPA / DHA/ALA (Omega 3) Value Market Share by Type (2015-2020) Figure 10. EPA / DHA/ALA (Omega 3) Consumed in Dietary Supplements Figure 11. Global EPA / DHA/ALA (Omega 3) Market: Dietary Supplements (2015-2020) (K Units) Figure 12. Global EPA / DHA/ALA (Omega 3) Market: Dietary Supplements (2015-2020) ($ Millions) Figure 13. EPA / DHA/ALA (Omega 3) Consumed in Functional Foods & Beverages Figure 14. Global EPA / DHA/ALA (Omega 3) Market: Functional Foods & Beverages (2015-2020) (K Units) Figure 15. Global EPA / DHA/ALA (Omega 3) Market: Functional Foods & Beverages (2015-2020) ($ Millions) Figure 16. EPA / DHA/ALA (Omega 3) Consumed in Others Figure 17. Global EPA / DHA/ALA (Omega 3) Market: Others (2015-2020) (K Units) Figure 18. Global EPA / DHA/ALA (Omega 3) Market: Others (2015-2020) ($ Millions) Figure 19. Global EPA / DHA/ALA (Omega 3) Consumption Market Share by Application (2015-2020) Figure 20. Global EPA / DHA/ALA (Omega 3) Value Market Share by Application (2015-2020) Figure 21. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Company in 2017 Figure 22. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Company in 2019 Figure 23. Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Company in 2017 Figure 24. Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Company in 2019 Figure 25. Global EPA / DHA/ALA (Omega 3) Sale Price by Company in 2019 Figure 26. Global EPA / DHA/ALA (Omega 3) Consumption Market Share by Regions 2015-2020 Figure 27. Global EPA / DHA/ALA (Omega 3) Value Market Share by Regions 2015-2020 Figure 28. Americas EPA / DHA/ALA (Omega 3) Consumption 2015-2020 (K Units) Figure 29. Americas EPA / DHA/ALA (Omega 3) Value 2015-2020 ($ Millions) Figure 30. APAC EPA / DHA/ALA (Omega 3) Consumption 2015-2020 (K Units) Figure 31. APAC EPA / DHA/ALA (Omega 3) Value 2015-2020 ($ Millions) Figure 32. Europe EPA / DHA/ALA (Omega 3) Consumption 2015-2020 (K Units) Figure 33. Europe EPA / DHA/ALA (Omega 3) Value 2015-2020 ($ Millions) Figure 34. Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption 2015-2020 (K Units) Figure 35. Middle East & Africa EPA / DHA/ALA (Omega 3) Value 2015-2020 ($ Millions) Figure 36. Americas EPA / DHA/ALA (Omega 3) Consumption Market Share by Countries in 2019 Figure 37. Americas EPA / DHA/ALA (Omega 3) Value Market Share by Countries in 2019 Figure 38. Americas EPA / DHA/ALA (Omega 3) Consumption Market Share by Type in 2019 Figure 39. Americas EPA / DHA/ALA (Omega 3) Consumption Market Share by Application in 2019 Figure 40. United States EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 41. United States EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 42. Canada EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 43. Canada EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 44. Mexico EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 45. Mexico EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 46. APAC EPA / DHA/ALA (Omega 3) Consumption Market Share by Countries in 2019 Figure 47. APAC EPA / DHA/ALA (Omega 3) Value Market Share by Regions in 2019 Figure 48. APAC EPA / DHA/ALA (Omega 3) Consumption Market Share by Type in 2019 Figure 49. APAC EPA / DHA/ALA (Omega 3) Consumption Market Share by Application in 2019 Figure 50. China EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 51. China EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 52. Japan EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 53. Japan EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 54. Korea EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 55. Korea EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 56. Southeast Asia EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 57. Southeast Asia EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 58. India EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 59. India EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 60. Australia EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 61. Australia EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 62. Europe EPA / DHA/ALA (Omega 3) Consumption Market Share by Countries in 2019 Figure 63. Europe EPA / DHA/ALA (Omega 3) Value Market Share by Countries in 2019 Figure 64. Europe EPA / DHA/ALA (Omega 3) Consumption Market Share by Type in 2019 Figure 65. Europe EPA / DHA/ALA (Omega 3) Consumption Market Share by Application in 2019 Figure 66. Germany EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 67. Germany EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 68. France EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 69. France EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 70. UK EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 71. UK EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 72. Italy EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 73. Italy EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 74. Russia EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 75. Russia EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 76. Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption Market Share by Countries in 2019 Figure 77. Middle East & Africa EPA / DHA/ALA (Omega 3) Value Market Share by Countries in 2019 Figure 78. Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption Market Share by Type in 2019 Figure 79. Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption Market Share by Application in 2019 Figure 80. Egypt EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 81. Egypt EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 82. South Africa EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 83. South Africa EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 84. Israel EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 85. Israel EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 86. Turkey EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 87. Turkey EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 88. GCC Countries EPA / DHA/ALA (Omega 3) Consumption Growth 2015-2020 (K Units) Figure 89. GCC Countries EPA / DHA/ALA (Omega 3) Value Growth 2015-2020 ($ Millions) Figure 90. Global EPA / DHA/ALA (Omega 3) Consumption Growth Rate Forecast (2021-2025) (K Units) Figure 91. Global EPA / DHA/ALA (Omega 3) Value Growth Rate Forecast (2021-2025) ($ Millions) Figure 92. Americas EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 93. Americas EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 94. APAC EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 95. APAC EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 96. Europe EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 97. Europe EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 98. Middle East & Africa EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 99. Middle East & Africa EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 100. United States EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 101. United States EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 102. Canada EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 103. Canada EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 104. Mexico EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 105. Mexico EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 106. Brazil EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 107. Brazil EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 108. China EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 109. China EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 110. Japan EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 111. Japan EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 112. Korea EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 113. Korea EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 114. Southeast Asia EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 115. Southeast Asia EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 116. India EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 117. India EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 118. Australia EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 119. Australia EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 120. Germany EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 121. Germany EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 122. France EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 123. France EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 124. UK EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 125. UK EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 126. Italy EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 127. Italy EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 128. Russia EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 129. Russia EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 130. Spain EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 131. Spain EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 132. Egypt EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 133. Egypt EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 134. South Africa EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 135. South Africa EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 136. Israel EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 137. Israel EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 138. Turkey EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 139. Turkey EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 140. GCC Countries EPA / DHA/ALA (Omega 3) Consumption 2021-2025 (K Units) Figure 141. GCC Countries EPA / DHA/ALA (Omega 3) Value 2021-2025 ($ Millions) Figure 142. EPAX EPA / DHA/ALA (Omega 3) Market Share (2018-2020) Figure 143. Golden Omega EPA / DHA/ALA (Omega 3) Market Share (2018-2020) Figure 144. Omega Protein EPA / DHA/ALA (Omega 3) Market Share (2018-2020) Figure 145. Croda EPA / DHA/ALA (Omega 3) Market Share (2018-2020) Figure 146. TASA EPA / DHA/ALA (Omega 3) Market Share (2018-2020) Figure 147. Polaris EPA / DHA/ALA (Omega 3) Market Share (2018-2020) Figure 148. KD Pharma EPA / DHA/ALA (Omega 3) Market Share (2018-2020) Figure 149. Auqi EPA / DHA/ALA (Omega 3) Market Share (2018-2020) Figure 150. GC Rieber EPA / DHA/ALA (Omega 3) Market Share (2018-2020)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by LP Information Inc

Global Artificial Pacemaker Market Growth 2020-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifti...

Global Artificial Heart Transplant Market Growth 2020-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifti...

Global Absorbable Coronary Stent Market Growth 2020-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifti...

Global Absorbable Cardiac Stent Market Growth 2020-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifti...

Global Artificial Heart Stent Market Growth 2020-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifti...

Publisher: LP Information Inc